Screener
Revolution Medicines, Inc. RVMD Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335104
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchases of property and equipment | (3,824) | (10,716) |
| Net cash provided by (used in) investing activities | (1,486,055) | 18,327 |
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock, net of issuance costs | 1,651,355 | — |
| Proceeds from the sale of future royalties, net of issuance costs | 245,000 | 250,000 |
| Proceeds from issuance of common stock pursuant to at-the-market offering, net of issuance costs | 226,730 | — |
| Proceeds from issuance of convertible senior notes, net | 487,068 | — |
| Proceeds from issuance of common stock under equity incentive plans | 41,053 | 2,828 |
Item 1. Financial Statements.
FAQ
- What is Revolution Medicines, Inc.'s stock issuance proceeds?
- Revolution Medicines, Inc. (RVMD) reported stock issuance proceeds of $1.64B in Q2 2026.
- How has Revolution Medicines, Inc.'s stock issuance proceeds changed year-over-year?
- Revolution Medicines, Inc.'s stock issuance proceeds increased by 184067.0% year-over-year, from -$891K to $1.64B.
- What is the long-term trend for Revolution Medicines, Inc.'s stock issuance proceeds?
- Over 2 years (2022 to 2025), Revolution Medicines, Inc.'s stock issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $248.13M to $0.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.
Ask your AI about Revolution Medicines, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude